🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆
Updated 04 Jul 2026 · HPRA open data

Aspire Pharma (Malta) Limited — Licensed Medicines

25 medicines held by Aspire Pharma (Malta) Limited on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 25 products held by Aspire Pharma (Malta) Limited
MedicineActive substanceLicence holderStatus
Bortezomib 1 mg powder for solution for injection
PA23142/012/001
 Bortezomib Aspire Pharma (Malta) Limited Not marketed
Bortezomib 2.5 mg powder for solution for injection
PA23142/012/003
 Bortezomib Aspire Pharma (Malta) Limited Not marketed
Bortezomib 3.5 mg powder for solution for injection
PA23142/012/002
 Bortezomib Aspire Pharma (Malta) Limited Not marketed
Buprenorphine 2 mg Sublingual Tablets
PA23142/003/001
 Buprenorphine hydrochloride Aspire Pharma (Malta) Limited Not marketed
Buprenorphine 8 mg Sublingual Tablets
PA23142/003/002
 Buprenorphine hydrochloride Aspire Pharma (Malta) Limited Not marketed
Clindamycin + Benzoyl Peroxide 10 mg/g + 50 mg/g gel
PA23142/015/001
 Clindamycin, Anhydrous Benzoyl Peroxide Aspire Pharma (Malta) Limited Not marketed
Clorom XL 500 mg Prolonged-Release Tablets
PA23142/006/001
 Clarithromycin Aspire Pharma (Malta) Limited Marketed
Ethambutol Hydrochloride 100mg film-coated tablets
PA23142/004/001
 Ethambutol hydrochloride Aspire Pharma (Malta) Limited Not marketed
Ethambutol Hydrochloride 400mg film-coated tablets
PA23142/004/002
 Ethambutol hydrochloride Aspire Pharma (Malta) Limited Not marketed
Eyreida 0.3 mg/ml eye drops, solution
PA23142/014/001
 Bimatoprost Aspire Pharma (Malta) Limited Not marketed
Eyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution
PA23142/013/001
 Bimatoprost, Timolol Maleate Aspire Pharma (Malta) Limited Not marketed
Leflunomide 10 mg film-coated tablets
PA23142/009/001
 Leflunomide Aspire Pharma (Malta) Limited Not marketed
Leflunomide 20mg film-coated tablets
PA23142/009/002
 Leflunomide Aspire Pharma (Malta) Limited Not marketed
Lorazepam 1mg tablets
PA23142/007/001
 Lorazepam Aspire Pharma (Malta) Limited Not marketed
Lorazepam 2.5 mg tablets
PA23142/007/002
 Lorazepam Aspire Pharma (Malta) Limited Not marketed
Methotrexate 10 mg tablets
PA23142/005/001
 Methotrexate Aspire Pharma (Malta) Limited Not marketed
Methotrexate 2.5mg tablets
PA23142/005/002
 Methotrexate Aspire Pharma (Malta) Limited Not marketed
Midodrine Hydrochloride Aspire 2.5 mg tablets
PA23142/008/001
 Midodrine hydrochloride Aspire Pharma (Malta) Limited Not marketed
Midodrine Hydrochloride Aspire 5 mg tablets
PA23142/008/002
 Midodrine hydrochloride Aspire Pharma (Malta) Limited Not marketed
Modrasone Cream 0.05% w/w
PA23142/011/001
 Alclometasone dipropionate Aspire Pharma (Malta) Limited Not marketed
Modrasone Ointment 0.05% w/w
PA23142/011/002
 Alclometasone dipropionate Aspire Pharma (Malta) Limited Not marketed
Vensir XL 150 mg prolonged-release hard capsules
PA23142/002/002
 Venlafaxine Aspire Pharma (Malta) Limited Not marketed
Vensir XL 75 mg prolonged-release hard capsules
PA23142/002/001
 Venlafaxine hydrochloride Aspire Pharma (Malta) Limited Not marketed
Zedbac 500 mg powder for concentrate for solution for infusion
PA23142/010/001
 Azithromycin dihydrate Aspire Pharma (Malta) Limited Not marketed
Zindaclin 1% Gel
PA23142/016/001
 CLINDAMYCIN PHOSPHATE Aspire Pharma (Malta) Limited Not marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.